Branched peptides as novel tumor-targeting agents for bladder cancer.
Andrea
A
Minervini
Giampaolo
G
Siena
Chiara
C
Falciani
Marco
M
Carini
Luisa
L
Bracci
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D018450:Disease Progression; D016503:Drug Delivery Systems / Q000379:methods; D006801:Humans; D009496:Neurotensin / Q000008:administration & dosage / Q000493:pharmacokinetics; D010455:Peptides / Q000008:administration & dosage* / Q000493:pharmacokinetics*; D012307:Risk Factors; D001749:Urinary Bladder Neoplasms / Q000188:drug therapy* / Q000378:metabolism* / Q000473:pathology
D000970:Antineoplastic Agents; D010455:Peptides; D009496:Neurotensin